This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
23 Feb 2021

Pharma Explained: What does 3D Printing actually mean for Pharmaceuticals?

Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone!

In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video presentations.

3D printing, also known as additive manufacturing, is a hot topic in the pharmaceutical sector, as it is seen as a technology that could ultimately revolutionise manufacturing. It actually refers to a variety of different processes in which materials are deposited, joined or solidified under computer control to create a three-dimensional object.

Join Jack Davenport, Business Development Manager, FabRx, in this CPHI Pharma Explained Video as he lifts the lid on the seven main applications of 3D printing and introduces the potential opportunities that the technology offers for the production of personalised medicines in the future.

Is there another term you want defined? Email us! [email protected]